Studies of different female rat models of hypothalamic obesity

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 3-4, 2011, Pages 131-137

  Elfers, Clinton ^a   Ralston, Melissa ^a   Roth, Christian L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

hypothalamic lesions; hypothalamic obesity; obesity phenotype; rat model.

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; DISEASE MODEL; FEMALE; HYPERINSULINEMIA; HYPERLEPTINEMIA; HYPERPHAGIA; HYPOTHALAMIC OBESITY; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; NONHUMAN; OBESITY; RAT; WEIGHT GAIN;

ANIMALS; ARCUATE NUCLEUS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HYPERINSULINISM; HYPERPHAGIA; HYPOTHALAMIC DISEASES; INSULIN; LEPTIN; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM GLUTAMATE; VENTROMEDIAL HYPOTHALAMIC NUCLEUS; WEIGHT GAIN;

EID: 79955500304     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2011.098     Document Type: Article

References (52)

1. Imura H, Kato Y, Nakai Y. Endocrine aspects of tumors arising from suprasellar, third ventricular regions. Prog Exp Tumor Res 1987;30:313-24.
2. Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C. Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 2003;88:5227-31. (Pubitemid 37452720)
3. Martinez-Luscher J, Holmer M. Potential effects of the invasive species Gracilaria vermiculophylla on Zostera marina metabolism and survival. Mar Environ Res 2010;69:345-9.
4. Curtis J, Daneman D, Hoffman HJ, Ehrlich RM. The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr Neurosurg 1994;21(Suppl 1):24-7. (Pubitemid 24337412)
5. Brauner R, Malandry F, Rappaport R, Pierre-Kahn A, Hirsch JF. [Craniopharyngioma in children. Endocrine evaluation and treatment. Apropos of 37 cases]. Arch Fr Pediatr 1987;44:765-9. (Pubitemid 18034561)
6. Sorva R. Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 1988;77:587-92.
7. Muller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 2008;69:193-202. (Pubitemid 351562907)
8. Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 2004;89:3298-305. (Pubitemid 38951896)
9. Mason PW, Krawiecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 2002;156:887-92. (Pubitemid 36343499)
10. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab 2007;92:4101-6. (Pubitemid 350074718)
11. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2003;88:2586-92. (Pubitemid 36724428)
12. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-95. (Pubitemid 44435142)
13. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. (Pubitemid 30205071)
14. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007;449:228-32. (Pubitemid 47402365)
15. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, et al. Hypothalamic mTOR signaling regulates food intake. Science 2006;312:927-30. (Pubitemid 43727328)
16. Vinchon M, Weill J, Delestret I, Dhellemmes P. Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst 2009;25:347-52.
17. Muller HL, Bueb K, Bartels U, Roth C, Harz K, et al. Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 2001;213:244-9. (Pubitemid 32801576)
18. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-6. (Pubitemid 36207799)
19. Lustig RH. Hypothalamic obesity: causes, consequences, treatment. Pediatr Endocrinol Rev 2008;6:220-7.
20. Roth CL, Blevins JE, Ralston M, Elfers C, Ogimoto K, et al. A novel rodent model that mimics the metabolic sequelae of obese craniopharyngioma patients. Pediatr Res, [published ahead of print, 7 Dec 2010].
21. Schoelch C, Hubschle T, Schmidt I, Nuesslein-Hildesheim B. MSG lesions decrease body mass of suckling-age rats by attenuating circadian decreases of energy expenditure. Am J Physiol Endocrinol Metab 2002;283:E604 - 11. (Pubitemid 35230499)
22. de Souza CT, Nunes WM, Gobatto CA, de Mello MA. Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol Chem Phys Med NMR 2003;35:43-53. (Pubitemid 38650099)
23. Dolnikoff M, Martin-Hidalgo A, Machado UF, Lima FB, Herrera E. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats. Int J Obes Relat Metab Disord 2001;25:426-33. (Pubitemid 32209820)
24. Leitner C, Bartness TJ. Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment. Am J Physiol Regul Integr Comp Physiol 2008;294:R775 - 83. (Pubitemid 351346953)
25. Tokunaga K, Fukushima M, Kemnitz JW, Bray GA. Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions. Endocrinology 1986;119:1708-11. (Pubitemid 17170541)
26. Dube MG, Kalra PS, Crowley WR, Kalra SP. Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 1995;690:275-8.
27. Choi S, Sparks R, Clay M, Dallman MF. Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology 1999;140:4426-33. (Pubitemid 30666105)
28. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd ed. New York: Academic Press, 1986.
29. Tokunaga K, Fukushima M, Kemnitz JW, Bray GA. Comparison of ventromedial and paraventricular lesions in rats that become obese. Am J Physiol 1986;251:R1221 - 7.
30. Bernardis LL, Patterson BD. Correlation between'Lee index'and carcass fat content in weanling and adult female rats with hypothalamic lesions. J Endocrinol 1968;40:527-8.
31. Blevins JE, Stanley BG, Reidelberger RD. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res 2000;860:1-10. (Pubitemid 30155832)
32. Roth CL, Hunneman DH, Gebhardt U, Stoffel-Wagner B, Reinehr T, et al. Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma. Pediatr Res 2007;61:496-501. (Pubitemid 46569307)
33. Holmer H, Pozarek G, Wirfalt E, Popovic V, Ekman B, et al. Reduced energy expenditure and impaired feeding-related signals but not high energy intake reinforces hypothalamic obesity in adults with childhood onset craniopharyngioma. J Clin Endocrinol Metab 2010;95:5395-402.
34. Kim RJ, Shah R, Tershakovec AM, Zemel BS, Sutton LN, et al. Energy expenditure in obesity associated with craniopharyngioma. Childs Nerv Syst 2010;26:913-7.
35. Brooks CM, Lambert HF. A study of the effect of limitation of food intake and the method of feeding on the rate of weight gain during hypothalamic obesity in the albino rat. Am J Physiol 1946;147:695-707.
36. Gardner PA, Kassam AB, Snyderman CH, Carrau RL, Mintz AH, et al. Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series. J Neurosurg 2008;109:6-16. (Pubitemid 351930516)
37. DeVile CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996;75:108-14. (Pubitemid 26276149)
38. Pascual JM, Carrasco R, Prieto R, Gonzalez-Llanos F, Alvarez F, et al. Craniopharyngioma classification. J Neurosurg 2008;109: 1180-2.
39. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 1969;166:386-8.
40. Kubota A, Nakagawa Y, Igarashi Y. Studies of gene expression in liver of insulin-like growth factor (IGF)-I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. Horm Metab Res 1994;26:497-503. (Pubitemid 24352157)
41. Bakke JL, Lawrence N, Bennett J, Robinson S, Bowers CY. Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 1978;26:220-8. (Pubitemid 8396379)
42. Donham RS, Ogilvie KM, Kerner TM, Stetson MH. Daily rhythms of luteinizing hormone and follicle-stimulating hormone persist in female hamsters sterilized by neonatal administration of monosodium glutamate. Biol Reprod 1990;43:392-6. (Pubitemid 20289485)
43. Poon TK, Cameron DP. Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity. Am J Physiol 1978;234:E532 - 4. (Pubitemid 9146144)
44. Dawson R Jr, Wallace DR, Gabriel SM. A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacol Biochem Behav 1989;32:391-8. (Pubitemid 19138987)
45. Roth CL, Zhang G, Ralston M, Ogimoko K, Morton GJ. Studies of different rat models of hypothalamic obesity. Hormone Res 2009;72 (Suppl 3):408.
46. Bray GA, Nishizawa Y. Ventromedial hypothalamus modulates fat mobilisation during fasting. Nature 1978;274:900-2. (Pubitemid 9004059)
47. Niijima A, Rohner-Jeanrenaud F, Jeanrenaud B. Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue. Am J Physiol 1984;247:R650 - 4. (Pubitemid 15200520)
48. Yoshimatsu H, Niijima A, Oomura Y, Yamabe K, Katafuchi T. Effects of hypothalamic lesion on pancreatic autonomic nerve activity in the rat. Brain Res 1984;303:147-52. (Pubitemid 14122516)
49. Hogan S, Himms-Hagen J, Coscina DV. Lack of diet-induced thermogenesis in brown adipose tissue of obese medial hypothalamic- lesioned rats. Physiol Behav 1985;35:287-94. (Pubitemid 16249568)
50. Tokunaga K, Matsuzawa Y, Fujioka S, Kobatake T, Keno Y, et al. PVN-lesioned obese rats maintain ambulatory activity and its circadian rhythm. Brain Res Bull 1991;26:393-6.
51. Sakaguchi T, Bray GA. Sympathetic activity following paraventricular injections of glucose and insulin. Brain Res Bull 1988;21:25-9. (Pubitemid 19268442)
52. King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav 2006;87:221-44. (Pubitemid 43188818)